Biotech Values

[bladerunner1717]

re: GERN CC

One analyst,God bless him, wanted to know how "Chip" could justify his $900,000 compensation or how the company could justify not running any company-sponsored trials. Chip's answers were rather lame, I thought. And the analyst kept hammering away at him. Toughest questioning I've ever heard on a small-cap biotech CC. It sounded like BTH was on the call. LOLOL

This is turning out to be a very bad investment for me.

And what exactly are they spending $33 million/year on, when they have no company-sponsored trials to run.


Bladerunner